Pro Medicus flags strong FY performance
Make us a preferred source
Make us a preferred source on Google
The news: Medical imaging provider Pro Medicus has flagged strong performance for this financial year despite currency volatility.
The numbers: The company said it has seen two significant client renewals so far this financial year, and its pipeline remains strong as new opportunities present themselves.
Pro Medicus shares are up 1.1% to $224.18 in early trading on the ASX. The stock has more than doubled so far this year.
The context: The deals included a $32 million contract extension in Australia and a $98 million renewal for its Visage 7 Viewer and Visage 7 Open Archive solutions in the US.
Pro Medicus chair Peter Kempen told shareholders at its annual general meeting today that the company’s results to date this financial year are ahead of budget, despite volatility in currency markets.
The Melbourne-based group provides medical imaging software and services to hospitals, imaging centres and healthcare groups globally.
What they said: “The board anticipates FY25 will be another strong year…we anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case,” he said.
The source: ASX announcement
